Hormone Molecular Biology and Clinical Investigation · 2012 · 93 citations · 160 references
MedicineOncologyPharmacologyBreast OncologyMolecular OncologyTranslational OncologyApoptosis ResistanceCancer ProgressionHormonal Cancer TherapyHormonal TherapyMetastatic Breast CancerSignal Transduction In CancerBreast Cancer Resistance MechanismsCancer Cell Line ModelsEstrogen Receptor SignalingHormone Receptor - Positive Breast CancerHormone Receptor-positive Breast Cancer TherapyHormone Receptor-positive DiseaseHormone Resistance MechanismsHormone-dependent Breast Cancer
Translational research for the treatment and prevention of breast cancer depends upon the four Ms: models, molecules, and mechanisms in order to create medicines. The process, to target the estrogen receptor (ER) in estrogen-dependent breast cancer, has yielded significant advances in patient survivorship and the first approved medicines (tamoxifen and raloxifene) to reduce the incidence of any cancer in high- or low-risk women. This review focuses on the critical role of the few ER-positive cell lines (MCF-7, T47D, BT474, ZR-75) that continue to advance our understanding of the estrogen-regulated biology of breast cancer. More importantly, the model cell lines have provided an opportunity to document the development and evolution of acquired antihormone resistance. The description of this evolutionary process that occurs in micrometastatic disease during up to a decade of adjuvant therapy would not be possible in the patient. The use of the MCF-7 breast cancer cell line in particular has been instrumental in discovering a vulnerability of ER-positive breast cancer exhaustively treated with antihormone therapy. Physiologic estradiol acts as an apoptotic trigger to cause tumor regression. These unanticipated findings in the laboratory have translated to clinical advances in our knowledge of the paradoxical role of estrogen in the life and death of breast cancer.
160
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
Garnet L. Anderson, Marian C. Limacher, Annlouise R. Assaf et al. · JAMA · 2004 · 4.5K citations · Full text
Medicine, Endocrinology, Gynecology +13
Trastuzumab-Induced Hepatotoxicity: A Case Report
D. Vucicevic, Elizabeth J. Carey, Nina J. Karlin · Breast Care · 2013 · 4.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17